Continuous glucose monitors are small, wearable devices that track blood sugar levels in real-time. While the devices are commonly prescribed to diabetics to titrate medications (e.g. insulin) to ...

Abbott and Dexcom settled all patent lawsuits related to continuous glucose monitors (CGMs). The two competitors, who lead the U.S. market for CGMs, agreed on Dec. 20 to resolve all outstanding ...

is proud to announce that the Dexcom G7 Continuous Glucose Monitoring (CGM) System has now been added to the Alberta Drug Benefit List. In addition, the Alberta government has expanded the ...

Dexcom on Tuesday announced its first generative AI feature for its Stelo biosensor that gives users a personalized weekly report about their glucose. The company has been building a generative AI ...

Notably, Dexcom continues to innovate, with a future iteration of its CGM on the way. Sayer described the next-generation ...

Comprehensive Analysis of the US Market Size and Growth Rate for Continuous ... landscape. Dexcom is a prominent player in the CGM market, known for its innovative glucose monitoring systems.

Abbott Laboratories and Decom will concentrate on competing in the huge market of potential continuous ... with Dexcom over all outstanding patent disputes relating to their glucose monitoring ...

Abbott and Dexcom have agreed to settle all of their remaining international legal disputes over patents related to their continuous glucose monitors ... FreeStyle Libre system’s LibreLinkUp ...

Dexcom is a developer and marketer of continuous glucose monitoring (CGM) systems for people with diabetes ... Dexcom G7 which is user-friendly and known for its accuracy, Dexcom Share System which ...